Literature DB >> 1704011

Thyrotropin-secreting pituitary adenomas: report of seven cases.

A Beckers1, R Abs, C Mahler, J L Vandalem, G Pirens, G Hennen, A Stevenaert.   

Abstract

Seven patients with hyperthyroidism due to a TSH-secreting pituitary macroadenoma have been observed of a total of 800 patients with pituitary tumors over a period of 15 yr. Serum TSH levels varied between 1.1-36.3 mU/L. The serum alpha-subunit level was low in 1 case, while in 4 other cases the concentration was elevated and varied between 3.7-7.8 micrograms/L. Serum TSH beta levels were normal in the 4 cases in which it was determined. Serum GH or PRL levels were elevated in 5 cases. In 1 patient the cosecretion of TSH, GH, and PRL was confirmed by immunocytochemical examination. Serum TSH and alpha-subunit responses to TRH, GnRH, CRF, GRF, dexamethasone, methimazole, T3, and bromocriptine administration were variable when studied. Serum TSH and alpha-subunit circadian rhythms were absent in 1 case and inverted in another. A serum alpha-subunit pulsatility without TSH pulses was observed in 1 patient. Five patients underwent transsphenoidal adenomectomy. Three of 4 patients operated on in our center were cured, but a recurrence of the adenoma was found in 1 of them after 5 yr. The fifth patient was not cured. Treatment with octreotide in 3 patients resulted in normalization of serum TSH, GH, and thyroid hormones levels. Cosecretion of PRL in 1 case and alpha-subunit in 2 cases was also inhibited. Partial tachyphylaxis occurred in 1 patient. In summary, heterogeneity in clinical presentation, hormonal expression, and therapeutic response appears to characterize these TSH-secreting adenomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704011     DOI: 10.1210/jcem-72-2-477

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  TSH-Secreting Pituitary Adenoma: Current Management and Review.

Authors:  M K Kole; J Goldman; J P Rock
Journal:  Skull Base Surg       Date:  1997

Review 2.  Subclinical hyperfunctioning pituitary adenomas: the silent tumors.

Authors:  Odelia Cooper; Shlomo Melmed
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

3.  Surgical management of thyrotropin-secreting pituitary adenomas.

Authors:  M Losa; P Mortini; A Franzin; R Barzaghi; C Mandelli; M Giovanelli
Journal:  Pituitary       Date:  1999-08       Impact factor: 4.107

Review 4.  Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment.

Authors:  N Sanno; A Teramoto; R Y Osamura
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

5.  Pituitary-hormone secretion by thyrotropinomas.

Authors:  Ferdinand Roelfsema; Simon Kok; Petra Kok; Alberto M Pereira; Nienke R Biermasz; Jan W Smit; Marijke Frolich; Daniel M Keenan; Johannes D Veldhuis; Johannes A Romijn
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

6.  Pericardial Effusion in the Emergency Department.

Authors:  Jordan E Pinsker; Robert J Ferry
Journal:  Endocrinologist       Date:  2004-07

7.  Imaging of dopamine D2 and somatostatin receptors in vivo using single-photon emission tomography in a patient with a TSH/PRL-producing pituitary macroadenoma.

Authors:  N P Verhoeff; F J Bemelman; W M Wiersinga; E A van Royen
Journal:  Eur J Nucl Med       Date:  1993-06

8.  Octreotide treatment does not affect the size of most non-functioning pituitary adenomas.

Authors:  M Gasperi; L Petrini; R Pilosu; M Nardi; A Marcello; F Mastio; L Bartalena; E Martino
Journal:  J Endocrinol Invest       Date:  1993 Jul-Aug       Impact factor: 4.256

Review 9.  Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management.

Authors:  Fatemeh G Amlashi; Nicholas A Tritos
Journal:  Endocrine       Date:  2016-01-21       Impact factor: 3.633

10.  Advances in the medical and surgical treatment of pituitary adenomas: the role of long-acting somatostatin analogs. Participants of the "Conference on Medical and Surgical Treatment of Pituitary Adenomas" (Zürich, 5th October, 1991).

Authors:  R Fahlbusch; M Giovanelli; M Buchfelder; M Losa
Journal:  J Endocrinol Invest       Date:  1993-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.